BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Sep 06, 2010
 |  BC Week In Review  |  Clinical News  |  Regulatory

Ezogabine regulatory update

Valeant and partner GlaxoSmithKline said FDA extended the PDUFA date for an NDA for ezogabine to Nov. 30 from Aug. 30. The partners attributed the delay to Valeant's submission of...

Read the full 129 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >